Quest Diagnostics Incorporated (DGX) has an average broker rating of 3.16, which is interpreted as a Hold, as rated by 14 equity analysts. Nevertheless, the majority of 12 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 3, which is also a Hold. 1 brokerage firm advices Strong Sell on the share due to lack of confidence about the future of the company. 1 considers that the stock is a Sell.
Quest Diagnostics Incorporated (DGX) stock is expected to deviate a maximum of $6.59 from the average target price of $80.1 for the short term period. 10 Street Experts have initiated coverage on the stock with the most promising target being $90 and the most muted being $70.
Company shares have received an average consensus rating of Hold for the current week Also, Brokerage firm Mizuho Securities downgrades its rating on Quest Diagnostics Incorporated (NYSE:DGX). The shares have been rated Neutral. Previously, the analysts had a Buy rating on the shares. The rating by the firm was issued on August 31, 2016.
Quest Diagnostics Incorporated (NYSE:DGX): The stock opened at $83.33 and touched an intraday high of $84.31 on Wednesday. During the day, the stock corrected to an intraday low of $83.3, however, the bulls stepped in and pushed the price higher to close in the green at $84.26 with a gain of 1.10% for the day. The total traded volume for the day was 1,250,315. The stock had closed at $83.34 in the previous trading session.
Quest Diagnostics Incorporated is a provider of diagnostic testing information services. The Company consists of two businesses: Diagnostic Information Services and Diagnostic Solutions. Diagnostic Information Services business, consists of two parts, develops and delivers diagnostic testing, information and services to patients, physicians, health plans, hospitals, accountable care organizations (ACOs), integrated delivery networks (IDNs), other commercial laboratories, patients and other customers. Diagnostics Information Services business also provides diagnostic information services, which includes providing clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services and drugs-of-abuse testing. Diagnostic Solutions includes the Companys other businesses, including central laboratory testing for pharmaceutical and medical device clinical trials, risk assessment services, diagnostic products and healthcare information technology.